Patents by Inventor Yong Xu

Yong Xu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8149840
    Abstract: A method, a system, and a processor for processing a network address translation (NAT) service are provided. The method includes: performing NAT service identification of a received message, and selecting a corresponding NAT service processor for processing a NAT service of a message that needs a NAT service processing from at least two NAT service processors. Through embodiments of the disclosure, a demand for the system to process a lot of NAT services within a short time is fulfilled, so as to increase the capacity of processing NAT services of the system.
    Type: Grant
    Filed: May 20, 2009
    Date of Patent: April 3, 2012
    Assignee: Huawei Technologies Co., Ltd.
    Inventors: Rihua Zhang, Zhiqiang Zhu, Guibin Hou, Xiangdong Meng, Shifeng Mao, Rong He, Wenhui Xie, Yuzhu Chen, Ran Su, Yong Xu, Zhijun Cheng
  • Publication number: 20120058997
    Abstract: The present invention provides protein kinase inhibitors comprising imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine compounds of the following structure (I) and (II): or a stereoisomer, prodrug or pharmaceutically acceptable salt thereof, wherein R, R1, R2 and X are as defined herein. Compositions and methods for using the same in the treatment of cancer and other Pim kinase-associated conditions are also disclosed.
    Type: Application
    Filed: July 21, 2011
    Publication date: March 8, 2012
    Applicant: SuperGen, Inc.
    Inventors: Yong Xu, Benjamin G. Brenning, Steven G. Kultgen, Xiaohui Liu, Michael Saunders, Koc-Kan Ho
  • Patent number: 8122761
    Abstract: A microcantilever sensor includes a supporting substrate, a cantilever spring element at least partially disposed over the support substrate, a probe layer disposed over the first side of the cantilever spring element, and a piezoresistive transducer attached to the second side of the cantilever spring element. The cantilever spring element is characterized by having a first side and a second side and comprising a polymer having a Young's modulus less than about 100 Gpa. Sensing systems that incorporate the cantilever sensor of the invention include a detector in communication with the piezoresistive transducer to provide measurements of surface strain changes in the piezoresistive transducer.
    Type: Grant
    Filed: January 20, 2006
    Date of Patent: February 28, 2012
    Assignee: Wayne State University
    Inventor: Yong Xu
  • Publication number: 20120045459
    Abstract: Methods for treating autophagy-related disorders with agents which modulate expression of the gene encoding tyrosine phosphatase receptor type sigma (PTPRS) or which modulate the biological activity of the PTPRS gene product (PTPsigma). Methods for modulating autophagy in a cell with agents which modulate expression of PTPRS or which modulate the biological activity of PTPsigma; and related diagnostic methods, screening methods, and agents.
    Type: Application
    Filed: May 5, 2010
    Publication date: February 23, 2012
    Applicant: Van Andel Research Institute
    Inventors: Jeffrey Paul MacKeigan, Katie Martin, Huaqiang Eric Xu, Yong Xu
  • Publication number: 20120033555
    Abstract: A routing method and apparatus are provided. The routing method includes the following steps: sending a probe frame that carries an address of a destination node to a neighboring node(s); receiving a response message returned; selecting one neighboring node from the neighboring node(s) that returns the response message as a next-hop node to which data is sent. A neighboring node with a cost parameter which is lower than a cost parameter in a routing table of the destination node is selected as the next-hop node. In the routing method, when a routing node forwards data, the route is found in real time by broadcasting a probe frame, and data may be sent as long as any one of the neighboring nodes that may arrive at the destination node is in an active state, and thus a data transmission delay is shortened.
    Type: Application
    Filed: October 14, 2011
    Publication date: February 9, 2012
    Applicant: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Yongjun LIU, Yong Xu
  • Publication number: 20110313298
    Abstract: The present invention relates to the field of optical imaging and therapeutics. More particularly, embodiments of the present invention provide minimally-invasive Fiberoptic Microneedle Devices (FMDs) for light-based therapeutics, which physically penetrate tissue and deliver light directly into the target area below the skin surface (FIG. 1). A preferred embodiment of the invention is a fiberoptic microneedle device comprising: (a) one or more silica-based needles capable of guiding light and comprising a length of about 0.5-6 mm, a base having an outer diameter in the range of about 100-150 micron, and a tip having an outer diameter in the range of about 5-20 micron; (b) a support member to which the needles are secured; (c) a ferrule comprising one or more holes for each of the needles, wherein the ferrule is operably configured to provide mechanical support to each needle at all or some portion of the length of the needle.
    Type: Application
    Filed: March 1, 2010
    Publication date: December 22, 2011
    Inventors: Christopher Rylander, Thomas A. Campbell, Ge Wang, Yong Xu, Mehmet Alpaslan Kosoglu
  • Publication number: 20110295428
    Abstract: A machine motion control system includes a number of moving parts for securing test electronic devices, a machine and an axis control card mounted on the machine. The machine includes a number of servo modules and a number of sensing units. The servo modules drive and control the corresponding moving parts on the machine. Each sensing unit is electrically connected to a corresponding moving part; the sensing units are operable to sense and transmit location information of the moving parts and the machine. The axis control card is electrically connected to the moving parts, the machine, and the sensing units. The axis control card receives location information of each moving part and processes the location information to generate a corresponding command signal, and transmits the generated command signal to the servo modules to control and adjust the moving parts.
    Type: Application
    Filed: October 5, 2010
    Publication date: December 1, 2011
    Applicants: HON HAI PRECISION INDUSTRY CO., LTD., HON FU JIN PRECISION INDUSTRY (ShenZhen) CO., LTD.
    Inventors: JIA-BIN WANG, HUA-YONG XU, GUO-JUN YU, TENG-TSUNG HUANG
  • Publication number: 20110288686
    Abstract: An exemplary embodiment of machine motion control system for testing electronic devices includes a machine and a control module electrically connected to the machine. The machine secures the electronic devices and includes a sensing unit and a servo unit, the sensing unit obtains different test parameters of the electronic devices to generate corresponding sensed signal. The control module includes a signal conversion unit electrically connected to the sensing unit and a main control circuit, the main control circuit is electrically connected to the signal conversion unit and the servo unit. The signal conversion unit converts the sensed signal into corresponding command signal, and the main control circuit drives and controls the servo unit to adjust the motion state and test strength on the electronic device according to the command signal.
    Type: Application
    Filed: September 20, 2010
    Publication date: November 24, 2011
    Applicants: HON HAI PRECISION INDUSTRY CO., LTD., HONG FU JIN PRECISION INDUSTRY (ShenZhen) CO., LTD
    Inventors: JIA-BIN WANG, HUA-YONG XU, GUO-JUN YU, TENG-TSUNG HUANG
  • Publication number: 20110282181
    Abstract: The present invention relates to the field of medical imaging. More particularly, embodiments of the invention relate to methods, systems, and devices for imaging, including for tomography-based applications. Embodiments of the invention include, for example, a computed tomography based imaging system comprising: (a) at least one wide-beam gray-scale imaging chain capable of performing a global scan of an object and acquiring projection data relating to the object; (b) at least one narrow-beam true-color imaging chain capable of performing a spectral interior scan of a region of interest (ROI) of and acquiring projection data relating to the object; (c) a processing module operably configured for: (1) receiving the projection data; (2) reconstructing the ROI into an image by analyzing the data with a color interior tomography algorithm, aided by an individualized gray-scale reconstruction of an entire field of view (FOV), including the ROI; and (d) a processor for executing the processing module.
    Type: Application
    Filed: November 12, 2010
    Publication date: November 17, 2011
    Inventors: Ge WANG, Yong Xu, Alexander Cong, Haiou Shen, Wenxiang Cong, Lin Yang, Yang Lu
  • Publication number: 20110281863
    Abstract: The present invention provides protein kinase inhibitors comprising imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine compounds of the following structure (I) and (II): or a stereoisomer, prodrug or pharmaceutically acceptable salt thereof, wherein R, R1, R2 and X are as defined herein. Compositions and methods for using the same in the treatment of cancer and other Pim kinase-associated conditions are also disclosed.
    Type: Application
    Filed: July 21, 2011
    Publication date: November 17, 2011
    Applicant: SuperGen, Inc.
    Inventors: David J. Bearss, Xiao-Hui Liu, Hariprasad Vankayalapati, Yong Xu
  • Patent number: 8058029
    Abstract: The present invention relates to compositions including: (1) isolated DNA encoding the StuI restriction endonuclease and isolated DNA encoding cognate and non-cognate methylase; (2) vectors and cells containing the isolated DNA; and (3) methods for producing the StuI restriction endonuclease.
    Type: Grant
    Filed: February 27, 2007
    Date of Patent: November 15, 2011
    Assignee: New England Biolabs, Inc.
    Inventors: Zhenyu Zhu, Shuang-Yong Xu
  • Publication number: 20110269772
    Abstract: Axl kinase inhibitory compounds are disclosed, as well as compositions and methods of using the same in the treatment of cancer and other conditions mediated by and/or associated with Axl kinase.
    Type: Application
    Filed: July 14, 2011
    Publication date: November 3, 2011
    Applicant: SUPERGEN, INC.
    Inventors: David J. BEARSS, Hariprasad VANKAYALAPATI, Yong XU
  • Publication number: 20110256092
    Abstract: Quinoline derivatives, particularly 4-anilinoquinoline derivatives, are provided. Such quinoline derivatives can be used for modulation of DNA methylation, such as effective inhibition of methylation of cytosine at the C-5 position, for example via selective inhibition of DNA methyltransferase DNMT1. Methods for synthesizing numerous 4-anilinoquinoline derivatives and for modulating DNA methylation are provided. Also provided are methods for formulating and administering these compounds or compositions to treat conditions such as cancer and hematological disorders.
    Type: Application
    Filed: March 14, 2011
    Publication date: October 20, 2011
    Applicant: SUPERGEN, INC.
    Inventors: Pasit Phiasivongsa, Sanjeev G. Redkar, Swarna Gamage, Darby Brooke, William Denny, David J. Bearss, Hariprasad Vankayalapati, Yong Xu, Krzysztof Swierczek
  • Publication number: 20110251211
    Abstract: A method for treating a subject having an inflammatory or auto-immune disease with a substituted isoxazolo pyridinone. Also, a method for administering a substituted isoxazolo pyridinone to a cell to retain or increase glucocorticoid receptor transrepression activity with only minimal glucocorticoid receptor transactivation activity.
    Type: Application
    Filed: January 13, 2010
    Publication date: October 13, 2011
    Inventors: Huaqiang Eric Xu, Yong Xu, Yuanzheng He
  • Publication number: 20110237497
    Abstract: A composition of a glucocorticoid receptor (GR) ligand, or analog thereof, and a V-ATPase inhibitor, or analog thereof. A method for administering such composition to a cell either to increase glucocorticoid transrepression activity or to increase glucocorticoid transactivation activity in the cell. Also, a method for treating a subject having an inflammatory or auto-immune disease by administering such composition.
    Type: Application
    Filed: November 18, 2010
    Publication date: September 29, 2011
    Inventors: HUAQIANG ERIC XU, Yong Xu, Yuanzheng He
  • Patent number: 7998966
    Abstract: Axl kinase inhibitory compounds are disclosed, as well as compositions and methods of using the same in the treatment of cancer and other conditions mediated by and/or associated with Axl kinase.
    Type: Grant
    Filed: April 11, 2008
    Date of Patent: August 16, 2011
    Assignee: Supergen, Inc.
    Inventors: David J. Bearss, Hariprasad Vankayalapati, Yong Xu
  • Publication number: 20110184503
    Abstract: A method of fabricating a three-dimensional neural probe includes the steps of: growing thermal oxide layer; depositing a layer of Au/Cr on the thermal oxide layer; patterning the layer of Au/Cr; depositing a layer of parylene C; etching the thermal oxide layer to release a plurality of islands; and folding the islands onto one another in stacked relation. The layer of Au/Cr is formed by an evaporation process, and the layer of parylene C is deposited to a thickness of approximately 8 ?m. DRIE is used to perform the etching, and HF is used to remove the thermal oxide. A spacer is disposed intermediate of two of the islands.
    Type: Application
    Filed: June 16, 2009
    Publication date: July 28, 2011
    Inventors: Yong Xu, Yuefa Li
  • Publication number: 20110149971
    Abstract: A method, an apparatus, and a system for processing packets are disclosed. The method is applied to a distributed architecture of multiple service boards; the distributed architecture includes a main control board, at least one service board, and at least one interface board. The method includes: determining a specified CPU corresponding to a received packet; and, by the service board corresponding to the CPU, processing the received packet. Through the embodiments of the present invention, the received packets are processed in the service board corresponding to the specified CPU. Therefore, the packets are evenly distributed to all service boards for being processed, the workload of the main control board is relieved, the service throughput is increased significantly, and the packet processing efficiency of the whole architecture is improved.
    Type: Application
    Filed: February 18, 2011
    Publication date: June 23, 2011
    Inventors: Zhiqiang Zhu, Rihua Zhang, Guibin Hou, Yong Xu, Wenhui Xie, Bo Ma, Guolu Gao, Xiaoping Lu, Cuihua Fu
  • Publication number: 20110151450
    Abstract: Methods and compositions are provided for engineering mutant enzymes with reduced star activity where the mutant enzymes have a fidelity index (FI) in a specified buffer that is greater than the FI of the non-mutated enzyme in the same buffer.
    Type: Application
    Filed: February 7, 2011
    Publication date: June 23, 2011
    Applicant: NEW ENGLAND BIOLABS, INC.
    Inventors: Zhenyu Zhu, Aine Quimby, Shengxi Guan, Dapeng Sun, Yishu Huang, Xuhui Lai, Siu-hong Chan, Xianghui Li, Shuang-Yong Xu, Chunhua Zhang
  • Patent number: 7943303
    Abstract: Methods are provided for engineering novel strand-specific nicking endonucleases by means of an in vivo enrichment of a plasmid library containing a randomly mutagenized restriction endonuclease gene. The plasmids contain adjacent to the gene a cleavable or nickable sequence for cleaving or nicking by the endonuclease product of the gene and a second recognition site for a second endonuclease. The plasmid library is used to transform unmodified host cells. Plasmids from the cultured transformed cells may be analyzed by an in vitro assay for nicking and the nicked plasmids pooled and used to transform host cells. The product is then pooled and the single-stranded specificity of the endonuclease is then determined. The product is either cloned after amplification or identified by use of a selectable marker.
    Type: Grant
    Filed: December 15, 2004
    Date of Patent: May 17, 2011
    Assignee: New England Biolabs, Inc.
    Inventors: Shuang-yong Xu, James Samuelson